Ambea ABCHIX:AMBEAS 83 5-Year Yield-on-Cost % is 1.72 as of Jul. 11, 2026, which is 2% below its 10-year median of 1.75. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 83/100 and a GF Value™ of kr121.31 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 280 Healthcare Providers & Services companies, Ambea AB ranks worse than 67.5% on this metric.
Ambea AB's yield on cost for the quarter that ended in Mar. 2026 was 1.72.
The historical rank and industry rank for Ambea AB's 5-Year Yield-on-Cost % or its related term are showing as below:
CHIX:AMBEAs'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.12 Med: 1.75 Max: 3.74
Current: 1.72
During the past 12 years, Ambea AB's highest Yield on Cost was 3.74. The lowest was 1.12. And the median was 1.75.
CHIX:AMBEAs's 5-Year Yield-on-Cost % is ranked worse than 67.5% of 280
companies
in the Healthcare Providers & Services industry
Industry Median: 2.945
vs CHIX:AMBEAs: 1.72
Ambea AB (CHIX:AMBEAs) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Ambea AB 5-Year Yield-on-Cost % Related Terms
CHIX:AMBEAS vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Ambea AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Ambea AB's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Ambea AB is calculated as
Ambea AB (CHIX:AMBEAS) has a 5-Year Yield-on-Cost % of 1.72 as of Jul. 11, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ambea AB and its competitors. This is near median its historical median of 1.75. Over the past decade, Ambea AB's 5-Year Yield-on-Cost % has ranged from 1.12 to 3.74. According to the industry distribution chart, Ambea AB ranks #189 out of 280 companies in the Healthcare Providers & Services industry, placing it in the top 67.5%.
Is Ambea AB's 5-Year Yield-on-Cost % too high?
Ambea AB's current 5-Year Yield-on-Cost % of 1.72 is near median its 10-year median of 1.75. Over the past 10 years, this metric has ranged from a low of 1.12 to a high of 3.74. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.95. Ambea AB's value of 1.72 is 41.6% below this industry median. Based on the distribution chart, Ambea AB ranks #189 out of 280 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ambea AB has a GF Score™ of 83/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #189 out of 280 companies for 5-Year Yield-on-Cost %. This places Ambea AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.95. Ambea AB's value of 1.72 is 41.6% below this benchmark. Historically, Ambea AB's own 5-Year Yield-on-Cost % has ranged from 1.12 to 3.74 over the past decade. While the company's 10-year median is 1.75 vs. the industry median of 2.95, Ambea AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.95, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambea AB's current 5-Year Yield-on-Cost % of 1.72 is 41.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ambea AB and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambea AB's current 5-Year Yield-on-Cost % is 1.72, which is near median its own 10-year median of 1.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Significantly Overvalued. The stock's GF Value™ is kr121.31, compared to a current price of kr144.20 — trading 18.9% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.72, which is near median its 10-year median of 1.75 and 41.6% below the Healthcare Providers & Services industry median of 2.95. Ambea AB's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current 5-Year Yield-on-Cost % is 1.72 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr144.20 is trading 18.9% above its estimated GF Value™ of kr121.31.
GuruFocus considers Ambea AB to be Significantly Overvalued.
Key valuation signals for CHIX:AMBEAS:
5-Year Yield-on-Cost %: 1.72 (near median its 10-year median of 1.75)
GF Value™: kr121.31 vs. price of kr144.20 (18.9% above fair value)
Industry Position: 41.6% below the Healthcare Providers & Services median (#189 of 280)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
83GF Score
Get the complete analysis for CHIX:AMBEAS
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 